{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Science Desk", "lead_paragraph": "Veterinarians around the country are reporting a strange phenomenon: spayed dogs and cats, even some puppies and kittens, are suddenly becoming hormonal. In female pets, the symptoms resemble heat: swollen genitals, bloody discharge and behavioral problems. Male animals are showing up with swollen breast tissue and hair loss. Standard treatments and even repeated operations have had no effect.", "headline": {"main": "When Hormone Creams Expose Others to Risks", "kicker": "WELL"}, "abstract": null, "print_page": "5", "word_count": 927, "_id": "4fd281d28eb7c8105d84e5e8", "snippet": "Veterinarians around the country are reporting a strange phenomenon: spayed dogs and cats, even some puppies and kittens, are suddenly becoming hormonal.     In female pets, the symptoms resemble heat: swollen genitals, bloody discharge and...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9C00E4D91139F935A15753C1A9669D8B63", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Tara", "rank": 1, "lastname": "PARKER-POPE"}], "original": "By TARA PARKER-POPE"}, "document_type": "article", "pub_date": "2010-10-26T00:00:00Z", "section_name": "Science; Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Science Desk", "lead_paragraph": "Veterinarians around the country are reporting a strange phenomenon: spayed dogs and cats, even some puppies and kittens, are suddenly becoming hormonal. In female pets, the symptoms resemble heat: swollen genitals, bloody discharge and behavioral problems. Male animals are showing up with swollen breast tissue and hair loss. Standard treatments and even repeated operations have had no effect.", "headline": {"main": "When Hormone Creams Expose Others to Risks", "kicker": "WELL"}, "abstract": "Some family members and pets are becoming inadvertently exposed to hormones through contact with women using hormone creams to counter symptoms of menopause; Food and Drug Administration has issued warnings about complications of contact with topical estrogen, but many vets and pediatricians are still unfamiliar with signs of such exposure; drawing (M)", "print_page": "5", "word_count": 927, "_id": "4fd29f188eb7c8105d88260b", "snippet": "Veterinarians around the country are reporting a strange phenomenon: spayed dogs and cats, even some puppies and kittens, are suddenly becoming hormonal.     In female pets, the symptoms resemble heat: swollen genitals, bloody discharge and...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9E00E6D71230F935A15753C1A9669D8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "subject", "value": "ESTROGEN"}, {"name": "subject", "value": "HORMONES"}, {"name": "subject", "value": "MENOPAUSE"}, {"name": "subject", "value": "PETS"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Tara", "rank": 1, "lastname": "PARKER-POPE"}], "original": "By TARA PARKER-POPE"}, "document_type": "article", "pub_date": "2010-10-26T00:00:00Z", "section_name": "Science; Health"}, {"type_of_material": "Letter", "blog": [], "news_desk": "Letters", "lead_paragraph": "A response to a news analysis about the long-term safety of drugs.", "headline": {"content_kicker": "Letter", "main": "Long-Term Benefits and Side Effects of Medications", "kicker": "Letter", "print_headline": "Long-Term Benefits and Side Effects of Medications", "sub": "(1 Letter)"}, "abstract": null, "print_page": "", "word_count": "193", "_id": "541bf4ba7988100a1c6608ac", "snippet": "A response to a news analysis about the long-term safety of drugs.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2010/10/25/opinion/lweb25drug.html", "multimedia": [], "subsection_name": null, "keywords": [{"rank": "1", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Medicine and Health", "name": "subject"}], "byline": [], "document_type": "article", "pub_date": "2010-10-25T00:00:00Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "National", "lead_paragraph": "Workplace testing is drawing complaints from employees who say they should not be fired for taking legal drugs.", "headline": {"main": "Drug Testing Poses Quandary for Employers", "sub": "Challenges for Employers ;", "print_headline": "Testing for Prescription Drugs Poses Quandary for Employers"}, "abstract": null, "print_page": "1", "word_count": "2278", "_id": "541c020b7988100a1c6609d4", "snippet": "Workplace testing is drawing complaints from employees who say they should not be fired for taking legal drugs.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2010/10/25/us/25drugs.html", "multimedia": [{"width": 190, "url": "images/2010/10/25/us/25drugs-g3/25drugs-g3-thumbWide.jpg", "height": 126, "subtype": "wide", "legacy": {"wide": "images/2010/10/25/us/25drugs-g3/25drugs-g3-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"width": 600, "url": "images/2010/10/25/us/25drugs_337-span/JP-DRUGS-2-articleLarge.jpg", "height": 330, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlarge": "images/2010/10/25/us/25drugs_337-span/JP-DRUGS-2-articleLarge.jpg", "xlargeheight": "330"}, "type": "image"}, {"width": 75, "url": "images/2010/10/25/us/25drugs_337-span/JP-DRUGS-2-thumbStandard.jpg", "height": 75, "subtype": "thumbnail", "legacy": {"thumbnailheight": "75", "thumbnail": "images/2010/10/25/us/25drugs_337-span/JP-DRUGS-2-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"rank": "1", "is_major": "N", "value": "Drug Abuse and Traffic", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Labor and Jobs", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Tests and Testing", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Accidents and Safety", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Pain-Relieving Drugs", "name": "subject"}, {"rank": "7", "is_major": "N", "value": "Dura Automotive Systems Incorporated", "name": "organizations"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "firstname": "Katie", "rank": 1, "lastname": "ZEZIMA"}, {"organization": "", "role": "reported", "firstname": "Abby", "rank": 2, "lastname": "GOODNOUGH"}], "original": "By KATIE ZEZIMA and ABBY GOODNOUGH"}, "document_type": "article", "pub_date": "2010-10-25T00:00:00Z", "section_name": "U.S."}, {"type_of_material": "Op-Ed", "blog": [], "news_desk": "Editorial", "lead_paragraph": "The war on drugs has become focused on marijuana, is being waged primarily against minorities and is being promoted by Democratic politicians.", "headline": {"seo": "Smoke and Horrors", "main": "Smoke and Horrors", "print_headline": "Smoke and Horrors", "content_kicker": "Op-Ed Columnist"}, "abstract": null, "print_page": "21", "word_count": "982", "_id": "541bfb217988100a1c660939", "snippet": "The war on drugs has become focused on marijuana, is being waged primarily against minorities and is being promoted by Democratic politicians.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2010/10/23/opinion/23blow.html", "multimedia": [{"subtype": "wide", "url": "images/2010/09/16/opinion/Blow_New/Blow_New-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2010/09/16/opinion/Blow_New/Blow_New-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2010/09/16/opinion/Blow_New/Blow_New-articleLarge.jpg", "height": 750, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2010/09/16/opinion/Blow_New/Blow_New-articleLarge.jpg", "xlargeheight": "750"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2010/09/16/opinion/Blow_New/Blow_New-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2010/09/16/opinion/Blow_New/Blow_New-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Drug Abuse and Traffic", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Blacks", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Law and Legislation", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Discrimination", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Minorities", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Hispanic-Americans", "is_major": "N", "rank": "6", "name": "subject"}, {"value": "Marijuana", "is_major": "N", "rank": "7", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Charles"}], "original": "By CHARLES M. BLOW"}, "document_type": "article", "pub_date": "2010-10-23T00:00:00Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Updated: Eli Lilly & Company, confronted with research setbacks and pending patent losses, reported a quarterly profit on Thursday that beat Wall Street estimates. It also raised its forecast for full-year 2010 profits, saying one reason was that the health care overhaul passed by Congress was costing it less than expected.", "headline": {"main": "Lilly Beats Estimates and Raises Full-Year Forecast", "kicker": "PRESCRIPTIONS"}, "abstract": "Eli Lilly & Co reports third-quarter profit of $1.3 billion, or $1.18 per share, up 38 percent from year-ago quarter; revenue was $5.65 billion; photo (M)", "print_page": "8", "word_count": 750, "_id": "4fd29c738eb7c8105d87df11", "snippet": "Updated: Eli Lilly & Company, confronted with research setbacks and pending patent losses, reported a quarterly profit on Thursday that beat Wall Street estimates.     It also raised its forecast for full-year 2010 profits, saying one reason was that...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9B01E4D81038F931A15753C1A9669D8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "LILLY, ELI, & CO"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "COMPANY REPORTS"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Duff", "rank": 1, "lastname": "WILSON"}], "original": "By DUFF WILSON"}, "document_type": "article", "pub_date": "2010-10-22T00:00:00Z", "section_name": "Business"}], "meta": {"hits": 6, "offset": 0, "time": 30}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}